
Patient-Centric Approach
Everything we do at TrialChoices revolves around our patient community. Patient safety and ensuring good clinical outcomes is why we come to work each day.
​
Our aim is to reduce SSU (study start-up) time from months and years to weeks. We also know that 85% of global trials are delayed.
SSU time can be precious for those with later stage illnesses and costly for research & trials.

Charities
Academia
Pharma

.png)
Key Benefits
UK patient data at scale, with speed
Access to potentially millions of patients with electronic records, with the associated population data analytics that could be explored. Rapid recruitment and SSU (study start-up) for niche and specialist off-label trials is a game changer.
The right patients, at the right time in the right place
We’ll work tirelessly with UK primary and secondary care, being agile with safe speed to get SSU (study start-up) done quickly. We want to have the most suitable patients ready for any study in weeks and not months.